S100A4 Is a Targetable Regulator of Immune Suppression in Glioblastoma
Glioblastoma (GBM) is a highly aggressive brain tumor that remains largely refractory to immunotherapy owing to a profoundly immunosuppressive tumor microe
Glioblastoma (GBM) is a highly aggressive brain tumor that remains largely refractory to immunotherapy owing to a profoundly immunosuppressive tumor microe